Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group
To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy. Data for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary p...
Saved in:
Published in | International journal of radiation oncology, biology, physics Vol. 115; no. 2; pp. 337 - 346 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy.
Data for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary pelvic tumors on INT-0091, INT-0154, and AEWS0031 were analyzed. Imaging data for patients who did not receive radiation were not available for central review; therefore, patients with surgery alone were not included. Cumulative incidence rates for local failure at 5 years from time of local control were calculated accounting for competing risks.
The most common pelvic subsite was sacrum (44.6%). RT was used in 68% of patients and S + RT in 32%. The local failure rate was 25.0% for RT and 6.3% for S + RT (P = .046). There was no statistically significant difference in local control modality by tumor characteristics. Tumors originating in the ischiopubic-acetabulum region were associated with the highest local failure incidence, 37.5% (P = .02, vs sacrum and iliac/buttock tumors), particularly those treated with RT (50.0%, P = .06). A higher incidence of local failure was seen with each additional 100 mL of tumor at diagnosis (P = .04). Multivariable analysis demonstrated RT alone (hazard ratio [HR], 5.1; P = .04), tumor subsite (particularly ischiopubic-acetabulum tumors; HR 4.6; P = .02), and increasing volume per 100 mL (HR, 1.2; P = .01) were associated with a higher incidence of local recurrence.
Combination surgery and RT is associated with improved local control in patients with pelvic Ewing sarcoma compared with definitive RT. Tumors involving the ischiopubic-acetabulum region and increasing tumor volume at diagnosis are associated with inferior local control. Tumor characteristics did not correlate with choice of local therapy modality suggesting an opportunity to develop best local therapy practices guidelines for future studies based on tumor features. |
---|---|
AbstractList | To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy.
Data for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary pelvic tumors on INT-0091, INT-0154, and AEWS0031 were analyzed. Imaging data for patients who did not receive radiation were not available for central review; therefore, patients with surgery alone were not included. Cumulative incidence rates for local failure at 5 years from time of local control were calculated accounting for competing risks.
The most common pelvic subsite was sacrum (44.6%). RT was used in 68% of patients and S + RT in 32%. The local failure rate was 25.0% for RT and 6.3% for S + RT (P = .046). There was no statistically significant difference in local control modality by tumor characteristics. Tumors originating in the ischiopubic-acetabulum region were associated with the highest local failure incidence, 37.5% (P = .02, vs sacrum and iliac/buttock tumors), particularly those treated with RT (50.0%, P = .06). A higher incidence of local failure was seen with each additional 100 mL of tumor at diagnosis (P = .04). Multivariable analysis demonstrated RT alone (hazard ratio [HR], 5.1; P = .04), tumor subsite (particularly ischiopubic-acetabulum tumors; HR 4.6; P = .02), and increasing volume per 100 mL (HR, 1.2; P = .01) were associated with a higher incidence of local recurrence.
Combination surgery and RT is associated with improved local control in patients with pelvic Ewing sarcoma compared with definitive RT. Tumors involving the ischiopubic-acetabulum region and increasing tumor volume at diagnosis are associated with inferior local control. Tumor characteristics did not correlate with choice of local therapy modality suggesting an opportunity to develop best local therapy practices guidelines for future studies based on tumor features. PURPOSETo identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy.METHODS AND MATERIALSData for 101 patients treated with definitive radiation therapy (RT) or both surgery and radiation (S + RT) to primary pelvic tumors on INT-0091, INT-0154, and AEWS0031 were analyzed. Imaging data for patients who did not receive radiation were not available for central review; therefore, patients with surgery alone were not included. Cumulative incidence rates for local failure at 5 years from time of local control were calculated accounting for competing risks.RESULTSThe most common pelvic subsite was sacrum (44.6%). RT was used in 68% of patients and S + RT in 32%. The local failure rate was 25.0% for RT and 6.3% for S + RT (P = .046). There was no statistically significant difference in local control modality by tumor characteristics. Tumors originating in the ischiopubic-acetabulum region were associated with the highest local failure incidence, 37.5% (P = .02, vs sacrum and iliac/buttock tumors), particularly those treated with RT (50.0%, P = .06). A higher incidence of local failure was seen with each additional 100 mL of tumor at diagnosis (P = .04). Multivariable analysis demonstrated RT alone (hazard ratio [HR], 5.1; P = .04), tumor subsite (particularly ischiopubic-acetabulum tumors; HR 4.6; P = .02), and increasing volume per 100 mL (HR, 1.2; P = .01) were associated with a higher incidence of local recurrence.CONCLUSIONSCombination surgery and RT is associated with improved local control in patients with pelvic Ewing sarcoma compared with definitive RT. Tumors involving the ischiopubic-acetabulum region and increasing tumor volume at diagnosis are associated with inferior local control. Tumor characteristics did not correlate with choice of local therapy modality suggesting an opportunity to develop best local therapy practices guidelines for future studies based on tumor features. |
Author | Krailo, Mark Janeway, Katherine A Womer, Richard B. DuBois, Steven G. Rose, Peter S. Grier, Holcombe E. Witten, Brent G. Gorlick, Richard G. Harmsen, William S. Laack, Nadia N.I. Marcus, Karen J. Randall, R. Lor Ahmed, Safia K. |
AuthorAffiliation | 9 Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine & Children’s Hospital of Philadelphia, Philadelphia, PA, USA 8 Department of Pediatrics, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA 7 Department of Orthopedic Surgery, UC Davis, Davis, CA, USA 3 Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA 1 Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA 2 Aurora Orthopedics, Milwaukee, MN, USA 5 Department of Preventative Medicine, University of Southern California, Los Angeles, CA, USA 4 Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA 10 Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA 6 Department of Radiation Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA |
AuthorAffiliation_xml | – name: 1 Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA – name: 9 Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine & Children’s Hospital of Philadelphia, Philadelphia, PA, USA – name: 10 Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA – name: 5 Department of Preventative Medicine, University of Southern California, Los Angeles, CA, USA – name: 7 Department of Orthopedic Surgery, UC Davis, Davis, CA, USA – name: 2 Aurora Orthopedics, Milwaukee, MN, USA – name: 4 Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA – name: 6 Department of Radiation Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA – name: 8 Department of Pediatrics, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center & Harvard Medical School, Boston, MA, USA – name: 3 Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA |
Author_xml | – sequence: 1 givenname: Safia K. surname: Ahmed fullname: Ahmed, Safia K. email: ahmed.safia@mayo.edu organization: Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona – sequence: 2 givenname: Brent G. surname: Witten fullname: Witten, Brent G. organization: Orthopedic Surgery, Aurora Orthopedics, Milwaukee, Minnesota – sequence: 3 givenname: William S. surname: Harmsen fullname: Harmsen, William S. organization: Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota – sequence: 4 givenname: Peter S. surname: Rose fullname: Rose, Peter S. organization: Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota – sequence: 5 givenname: Mark surname: Krailo fullname: Krailo, Mark organization: Department of Preventative Medicine, University of Southern California, Los Angeles, California – sequence: 6 givenname: Karen J. surname: Marcus fullname: Marcus, Karen J. organization: Department of Radiation Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts – sequence: 7 givenname: R. Lor surname: Randall fullname: Randall, R. Lor organization: Department of Orthopedic Surgery, UC Davis, Davis, California – sequence: 8 givenname: Steven G. surname: DuBois fullname: DuBois, Steven G. organization: Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts – sequence: 9 givenname: Katherine A surname: Janeway fullname: Janeway, Katherine A organization: Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts – sequence: 10 givenname: Richard B. surname: Womer fullname: Womer, Richard B. organization: Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine & Children's Hospital of Philadelphia, Philadelphia, Pennsylvania – sequence: 11 givenname: Holcombe E. surname: Grier fullname: Grier, Holcombe E. organization: Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center & Harvard Medical School, Boston, Massachusetts – sequence: 12 givenname: Richard G. surname: Gorlick fullname: Gorlick, Richard G. organization: Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas – sequence: 13 givenname: Nadia N.I. surname: Laack fullname: Laack, Nadia N.I. organization: Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36302496$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU-PUyEUxYkZ43RGP4KGnW5agfeH91xommY6Y9KkzVijO8KD25aGwhNoTf1mfruh6TjRlQvC4vzOuXDPFbpw3gFCrykZUULr99uR2Qbf9SNGGBsRPqJNSZ6hAW14Oyyq6vsFGpCiJsMi05foKsYtIYRSXr5Al0VdEFa29QD9Hjtpj9FE7Fd45pW0eOJdCt7i-T4pv4OIpdN4Yo0zJ3UR_Nr5mIzCU6mSDxEbd3aaX6DxAuwhazc_jVvjLzLkCIkXMhlwKeJlAJky9c2kDb6X2mTBO7zcQJD98QMe43vofUh4GvwOpw3gycZYHcC9jXjulLd-fcS3we_7l-j5StoIrx7va_R1erOc3A1n89vPk_FsqMqap6FqOemAdQQ6zphsQVclbXTeVtN2QGoOilOmGUApSUGari67FZWQT1Xruiqu0cdzbr_vdqBV_keQVvTB7GQ4Ci-N-FdxZiPW_iDapmirhuSAd48Bwf_YQ0xiZ6ICa6UDv4-C8YIUlDN-QqszqoKPMcDqaQwl4lS72Ipz7eJUuyBcnGrPvjd_v_HJ9afnDHw6A5A3dTAQRFS5EQXaBFBJaG_-M-IB8xnHHA |
CitedBy_id | crossref_primary_10_1016_j_ijrobp_2023_03_058 crossref_primary_10_3390_cancers15051623 crossref_primary_10_1016_j_radonc_2024_110270 crossref_primary_10_1007_s15004_023_9871_7 crossref_primary_10_1016_j_ijrobp_2023_03_061 |
Cites_doi | 10.1097/CORR.0000000000000962 10.1016/j.ijrobp.2016.04.001 10.1200/JCO.21.00358 10.1002/jso.24081 10.1016/S0360-3016(02)03797-5 10.1200/JCO.2011.41.5703 10.1002/jso.20752 10.1016/j.suronc.2015.11.002 10.1200/JCO.2006.05.9188 10.1056/NEJMoa020890 10.1016/j.ijrobp.2008.02.023 10.1016/j.ijrobp.2017.08.020 10.1016/j.ejca.2012.03.017 10.1016/j.ejca.2016.03.075 10.1016/j.ijrobp.2019.06.504 10.1200/JCO.2008.19.1478 10.1002/pbc.26504 10.1016/j.ejso.2021.05.027 10.1093/annonc/mdm521 10.2106/JBJS.O.00362 10.1016/j.ijrobp.2007.12.014 10.1002/1097-0142(19951015)76:8<1388::AID-CNCR2820760814>3.0.CO;2-F |
ContentType | Journal Article |
Copyright | 2022 Elsevier Inc. Copyright © 2022 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier Inc. – notice: Copyright © 2022 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1016/j.ijrobp.2022.07.1840 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-355X |
EndPage | 346 |
ExternalDocumentID | 10_1016_j_ijrobp_2022_07_1840 36302496 S0360301622025901 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: U10 CA180899 – fundername: NCI NIH HHS grantid: P30 CA015083 – fundername: NCI NIH HHS grantid: U10 CA180886 |
GroupedDBID | --- --K .1- .FO 0R~ 1B1 1P~ 1RT 1~5 4.4 457 4G. 53G 5RE 7-5 AAEDT AAEDW AAIAV AALRI AAWTL AAXUO ABJNI ABLJU ABNEU ABOCM ABUDA ACGFS ACIUM ADBBV AENEX AEVXI AFCTW AFRHN AFTJW AGZHU AHHHB AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS ALXNB AMRAJ BELOY DU5 EBS EFJIC F5P FDB GBLVA HED HMO IHE J1W KOM LX3 M41 MO0 O9- OC~ OO- RNS ROL RPZ SDG SEL SES SSZ UV1 XH2 Z5R ZA5 ~S- AFJKZ AKRWK CGR CUY CVF ECM EIF NPM RIG .55 .GJ 29J 5VS AAQFI AAQQT AAQXK AAYXX ABEFU ADMUD ADPAM ADVLN AFFNX AGRDE ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB FIRID G-2 HMK HVGLF HX~ HZ~ NQ- R2- SAE SEW UDS X7M XPP ZGI 7X8 5PM |
ID | FETCH-LOGICAL-c467t-c970be2b0eb722a9ed5418d18489be067ec712d2ee4a0308b64bf1aef1a56d653 |
ISSN | 0360-3016 |
IngestDate | Tue Sep 17 21:30:35 EDT 2024 Fri Oct 25 00:31:41 EDT 2024 Thu Sep 26 18:25:37 EDT 2024 Sat Nov 02 12:22:10 EDT 2024 Fri Feb 23 02:37:05 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | Copyright © 2022 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c467t-c970be2b0eb722a9ed5418d18489be067ec712d2ee4a0308b64bf1aef1a56d653 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839580 |
PMID | 36302496 |
PQID | 2730317270 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9839580 proquest_miscellaneous_2730317270 crossref_primary_10_1016_j_ijrobp_2022_07_1840 pubmed_primary_36302496 elsevier_sciencedirect_doi_10_1016_j_ijrobp_2022_07_1840 |
PublicationCentury | 2000 |
PublicationDate | 2023-02-01 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 02 year: 2023 text: 2023-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | International journal of radiation oncology, biology, physics |
PublicationTitleAlternate | Int J Radiat Oncol Biol Phys |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Hesla, Tsagozis, Jebsen (bib0009) 2016; 98 Talleur, Navid, Spunt (bib0005) 2016; 96 Indelicato, Keole, Shahlaee (bib0018) 2008; 72 Donati, Yin, Di Bella (bib0015) 2007; 96 Lex, Kurisunkal, Kaneuchi (bib0024) 2021; 47 Gaspar, Rey, Berard (bib0013) 2012; 48 Kneisl, Rosenberg, Anderson (bib0014) 2017 Ng, Jones, Bompadre (bib0022) 2015; 112 Ahmed, Randall, DuBois (bib0001) 2017; 99 Yock, Krailo, Fryer (bib0004) 2006; 24 Andreou, Ranft, Gosheger (bib0002) 2020; 478 Rodriguez-Galindo, Navid, Liu (bib0008) 2008; 19 Granowetter, Womer, Devidas (bib0011) 2009; 27 Leavey, Laack, Krailo (bib0020) 2021; 39 Laskar, Sinha, Chatterjee (bib0006) 2019; 105 Yang, Eckardt, Eilber (bib0023) 1995; 76 Werier, Yao, Caudrelier (bib0017) 2016; 25 Foulon, Brennan, Gaspar (bib0021) 2016; 61 Grier, Krailo, Tarbell (bib0010) 2003; 348 Dirksen, Jurgens, Ranft (bib0019) 2016; 63 Ahmed, Robinson, Arndt (bib0007) 2017; 64 Indelicato, Keole, Shahlaee (bib0016) 2008; 72 Schuck, Ahrens, Paulussen (bib0003) 2003; 55 Womer, West, Krailo (bib0012) 2012; 30 Granowetter (10.1016/j.ijrobp.2022.07.1840_bib0011) 2009; 27 Donati (10.1016/j.ijrobp.2022.07.1840_bib0015) 2007; 96 Kneisl (10.1016/j.ijrobp.2022.07.1840_bib0014) 2017 Andreou (10.1016/j.ijrobp.2022.07.1840_bib0002) 2020; 478 Foulon (10.1016/j.ijrobp.2022.07.1840_bib0021) 2016; 61 Rodriguez-Galindo (10.1016/j.ijrobp.2022.07.1840_bib0008) 2008; 19 Ng (10.1016/j.ijrobp.2022.07.1840_bib0022) 2015; 112 Indelicato (10.1016/j.ijrobp.2022.07.1840_bib0018) 2008; 72 Ahmed (10.1016/j.ijrobp.2022.07.1840_bib0001) 2017; 99 Dirksen (10.1016/j.ijrobp.2022.07.1840_bib0019) 2016; 63 Talleur (10.1016/j.ijrobp.2022.07.1840_bib0005) 2016; 96 Yang (10.1016/j.ijrobp.2022.07.1840_bib0023) 1995; 76 Laskar (10.1016/j.ijrobp.2022.07.1840_bib0006) 2019; 105 Indelicato (10.1016/j.ijrobp.2022.07.1840_bib0016) 2008; 72 Gaspar (10.1016/j.ijrobp.2022.07.1840_bib0013) 2012; 48 Leavey (10.1016/j.ijrobp.2022.07.1840_bib0020) 2021; 39 Womer (10.1016/j.ijrobp.2022.07.1840_bib0012) 2012; 30 Ahmed (10.1016/j.ijrobp.2022.07.1840_bib0007) 2017; 64 Lex (10.1016/j.ijrobp.2022.07.1840_bib0024) 2021; 47 Schuck (10.1016/j.ijrobp.2022.07.1840_bib0003) 2003; 55 Werier (10.1016/j.ijrobp.2022.07.1840_bib0017) 2016; 25 Yock (10.1016/j.ijrobp.2022.07.1840_bib0004) 2006; 24 Grier (10.1016/j.ijrobp.2022.07.1840_bib0010) 2003; 348 Hesla (10.1016/j.ijrobp.2022.07.1840_bib0009) 2016; 98 |
References_xml | – volume: 64 year: 2017 ident: bib0007 article-title: Pelvis Ewing sarcoma: Local control and survival in the modern era publication-title: Pediatr Blood Cancer contributor: fullname: Arndt – volume: 76 start-page: 1388 year: 1995 end-page: 1397 ident: bib0023 article-title: Surgical indications for Ewing's sarcoma of the pelvis publication-title: Cancer contributor: fullname: Eilber – volume: 98 start-page: 199 year: 2016 end-page: 210 ident: bib0009 article-title: Improved prognosis for patients with ewing sarcoma in the sacrum compared with the innominate bones: The Scandinavian Sarcoma Group Experience publication-title: J Bone Joint Surg Am contributor: fullname: Jebsen – volume: 25 start-page: 16 year: 2016 end-page: 23 ident: bib0017 article-title: A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy publication-title: Surg Oncol contributor: fullname: Caudrelier – volume: 99 start-page: 1286 year: 2017 end-page: 1294 ident: bib0001 article-title: Identification of patients with localized Ewing sarcoma at higher risk for local failure: A Report from the Children's Oncology Group publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: DuBois – volume: 30 start-page: 4148 year: 2012 end-page: 4154 ident: bib0012 article-title: Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group publication-title: J Clin Oncol contributor: fullname: Krailo – start-page: 471 year: 2017 end-page: 486 ident: bib0014 article-title: Bone publication-title: AJCC Cancer Staging Manual contributor: fullname: Anderson – volume: 19 start-page: 814 year: 2008 end-page: 820 ident: bib0008 article-title: Prognostic factors for local and distant control in Ewing sarcoma family of tumors publication-title: Ann Oncol contributor: fullname: Liu – volume: 48 start-page: 1376 year: 2012 end-page: 1385 ident: bib0013 article-title: Risk adapted chemotherapy for localised Ewing's sarcoma of bone: The French EW93 study publication-title: Eur J Cancer contributor: fullname: Berard – volume: 63 year: 2016 ident: bib0019 article-title: Local control and survival in pelvic Ewing sarcoma (EwS) in the Euro-Ewing99 trial publication-title: Pediatr Blood Cancer contributor: fullname: Ranft – volume: 24 start-page: 3838 year: 2006 end-page: 3843 ident: bib0004 article-title: Local control in pelvic Ewing sarcoma: analysis from INT-0091—A report from the Children's Oncology Group publication-title: J Clin Oncol contributor: fullname: Fryer – volume: 348 start-page: 694 year: 2003 end-page: 701 ident: bib0010 article-title: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone publication-title: New Engl J Med contributor: fullname: Tarbell – volume: 105 start-page: S62 year: 2019 ident: bib0006 article-title: Radiotherapy dose escalation in unresectable Ewing's sarcoma/PNET: Final results of a phase III randomized controlled trial publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Chatterjee – volume: 72 start-page: 41 year: 2008 end-page: 48 ident: bib0016 article-title: Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: The University of Florida experience publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Shahlaee – volume: 112 start-page: 861 year: 2015 end-page: 865 ident: bib0022 article-title: The effect of surgery with radiation on pelvic Ewing sarcoma survival publication-title: J Surg Oncol contributor: fullname: Bompadre – volume: 96 start-page: 19 year: 2007 end-page: 25 ident: bib0015 article-title: Local and distant control in non-metastatic pelvic Ewing's sarcoma patients publication-title: J Surg Oncol contributor: fullname: Di Bella – volume: 55 start-page: 168 year: 2003 end-page: 177 ident: bib0003 article-title: Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Paulussen – volume: 27 start-page: 2536 year: 2009 end-page: 2541 ident: bib0011 article-title: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study publication-title: J Clin Oncol contributor: fullname: Devidas – volume: 47 start-page: 2618 year: 2021 end-page: 2626 ident: bib0024 article-title: Pelvic Ewing sarcoma: Should all patients receive pre-operative radiotherapy, or should it be delivered selectively? publication-title: Eur J Surg Oncol contributor: fullname: Kaneuchi – volume: 96 start-page: 119 year: 2016 end-page: 126 ident: bib0005 article-title: Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Spunt – volume: 61 start-page: 128 year: 2016 end-page: 136 ident: bib0021 article-title: Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group publication-title: Eur J Cancer contributor: fullname: Gaspar – volume: 72 start-page: 871 year: 2008 end-page: 877 ident: bib0018 article-title: Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity publication-title: Int J Radiat Oncol Biol Phys contributor: fullname: Shahlaee – volume: 39 start-page: 4029 year: 2021 end-page: 4038 ident: bib0020 article-title: Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic Ewing sarcoma: A Children's Oncology Group Report publication-title: J Clin Oncol contributor: fullname: Krailo – volume: 478 start-page: 290 year: 2020 end-page: 302 ident: bib0002 article-title: Which factors are associated with local control and survival of patients with localized pelvic Ewing's sarcoma? A retrospective analysis of data from the Euro-EWING99 trial publication-title: Clin Orthop Relat Res contributor: fullname: Gosheger – volume: 478 start-page: 290 year: 2020 ident: 10.1016/j.ijrobp.2022.07.1840_bib0002 article-title: Which factors are associated with local control and survival of patients with localized pelvic Ewing's sarcoma? A retrospective analysis of data from the Euro-EWING99 trial publication-title: Clin Orthop Relat Res doi: 10.1097/CORR.0000000000000962 contributor: fullname: Andreou – volume: 96 start-page: 119 year: 2016 ident: 10.1016/j.ijrobp.2022.07.1840_bib0005 article-title: Limited margin radiation therapy for children and young adults with Ewing sarcoma achieves high rates of local tumor control publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2016.04.001 contributor: fullname: Talleur – volume: 39 start-page: 4029 year: 2021 ident: 10.1016/j.ijrobp.2022.07.1840_bib0020 article-title: Phase III trial adding vincristine-topotecan-cyclophosphamide to the initial treatment of patients with nonmetastatic Ewing sarcoma: A Children's Oncology Group Report publication-title: J Clin Oncol doi: 10.1200/JCO.21.00358 contributor: fullname: Leavey – volume: 112 start-page: 861 year: 2015 ident: 10.1016/j.ijrobp.2022.07.1840_bib0022 article-title: The effect of surgery with radiation on pelvic Ewing sarcoma survival publication-title: J Surg Oncol doi: 10.1002/jso.24081 contributor: fullname: Ng – volume: 55 start-page: 168 year: 2003 ident: 10.1016/j.ijrobp.2022.07.1840_bib0003 article-title: Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(02)03797-5 contributor: fullname: Schuck – volume: 30 start-page: 4148 year: 2012 ident: 10.1016/j.ijrobp.2022.07.1840_bib0012 article-title: Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group publication-title: J Clin Oncol doi: 10.1200/JCO.2011.41.5703 contributor: fullname: Womer – volume: 96 start-page: 19 year: 2007 ident: 10.1016/j.ijrobp.2022.07.1840_bib0015 article-title: Local and distant control in non-metastatic pelvic Ewing's sarcoma patients publication-title: J Surg Oncol doi: 10.1002/jso.20752 contributor: fullname: Donati – volume: 25 start-page: 16 year: 2016 ident: 10.1016/j.ijrobp.2022.07.1840_bib0017 article-title: A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy publication-title: Surg Oncol doi: 10.1016/j.suronc.2015.11.002 contributor: fullname: Werier – volume: 24 start-page: 3838 year: 2006 ident: 10.1016/j.ijrobp.2022.07.1840_bib0004 article-title: Local control in pelvic Ewing sarcoma: analysis from INT-0091—A report from the Children's Oncology Group publication-title: J Clin Oncol doi: 10.1200/JCO.2006.05.9188 contributor: fullname: Yock – volume: 348 start-page: 694 year: 2003 ident: 10.1016/j.ijrobp.2022.07.1840_bib0010 article-title: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone publication-title: New Engl J Med doi: 10.1056/NEJMoa020890 contributor: fullname: Grier – volume: 72 start-page: 871 year: 2008 ident: 10.1016/j.ijrobp.2022.07.1840_bib0018 article-title: Definitive radiotherapy for ewing tumors of extremities and pelvis: Long-term disease control, limb function, and treatment toxicity publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2008.02.023 contributor: fullname: Indelicato – volume: 63 year: 2016 ident: 10.1016/j.ijrobp.2022.07.1840_bib0019 article-title: Local control and survival in pelvic Ewing sarcoma (EwS) in the Euro-Ewing99 trial publication-title: Pediatr Blood Cancer contributor: fullname: Dirksen – volume: 99 start-page: 1286 year: 2017 ident: 10.1016/j.ijrobp.2022.07.1840_bib0001 article-title: Identification of patients with localized Ewing sarcoma at higher risk for local failure: A Report from the Children's Oncology Group publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2017.08.020 contributor: fullname: Ahmed – volume: 48 start-page: 1376 year: 2012 ident: 10.1016/j.ijrobp.2022.07.1840_bib0013 article-title: Risk adapted chemotherapy for localised Ewing's sarcoma of bone: The French EW93 study publication-title: Eur J Cancer doi: 10.1016/j.ejca.2012.03.017 contributor: fullname: Gaspar – volume: 61 start-page: 128 year: 2016 ident: 10.1016/j.ijrobp.2022.07.1840_bib0021 article-title: Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group publication-title: Eur J Cancer doi: 10.1016/j.ejca.2016.03.075 contributor: fullname: Foulon – volume: 105 start-page: S62 year: 2019 ident: 10.1016/j.ijrobp.2022.07.1840_bib0006 article-title: Radiotherapy dose escalation in unresectable Ewing's sarcoma/PNET: Final results of a phase III randomized controlled trial publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2019.06.504 contributor: fullname: Laskar – volume: 27 start-page: 2536 year: 2009 ident: 10.1016/j.ijrobp.2022.07.1840_bib0011 article-title: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: A Children's Oncology Group Study publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.1478 contributor: fullname: Granowetter – volume: 64 year: 2017 ident: 10.1016/j.ijrobp.2022.07.1840_bib0007 article-title: Pelvis Ewing sarcoma: Local control and survival in the modern era publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.26504 contributor: fullname: Ahmed – volume: 47 start-page: 2618 year: 2021 ident: 10.1016/j.ijrobp.2022.07.1840_bib0024 article-title: Pelvic Ewing sarcoma: Should all patients receive pre-operative radiotherapy, or should it be delivered selectively? publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2021.05.027 contributor: fullname: Lex – volume: 19 start-page: 814 year: 2008 ident: 10.1016/j.ijrobp.2022.07.1840_bib0008 article-title: Prognostic factors for local and distant control in Ewing sarcoma family of tumors publication-title: Ann Oncol doi: 10.1093/annonc/mdm521 contributor: fullname: Rodriguez-Galindo – volume: 98 start-page: 199 year: 2016 ident: 10.1016/j.ijrobp.2022.07.1840_bib0009 article-title: Improved prognosis for patients with ewing sarcoma in the sacrum compared with the innominate bones: The Scandinavian Sarcoma Group Experience publication-title: J Bone Joint Surg Am doi: 10.2106/JBJS.O.00362 contributor: fullname: Hesla – volume: 72 start-page: 41 year: 2008 ident: 10.1016/j.ijrobp.2022.07.1840_bib0016 article-title: Impact of local management on long-term outcomes in Ewing tumors of the pelvis and sacral bones: The University of Florida experience publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2007.12.014 contributor: fullname: Indelicato – start-page: 471 year: 2017 ident: 10.1016/j.ijrobp.2022.07.1840_bib0014 article-title: Bone contributor: fullname: Kneisl – volume: 76 start-page: 1388 year: 1995 ident: 10.1016/j.ijrobp.2022.07.1840_bib0023 article-title: Surgical indications for Ewing's sarcoma of the pelvis publication-title: Cancer doi: 10.1002/1097-0142(19951015)76:8<1388::AID-CNCR2820760814>3.0.CO;2-F contributor: fullname: Yang |
SSID | ssj0001174 |
Score | 2.4809535 |
Snippet | To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated... PURPOSETo identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 337 |
SubjectTerms | Bone Neoplasms - pathology Bone Neoplasms - radiotherapy Child Combined Modality Therapy Humans Neoplasm Recurrence, Local Pelvic Neoplasms Prognosis Retrospective Studies Sacrum Sarcoma, Ewing - pathology Sarcoma, Ewing - radiotherapy |
Title | Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group |
URI | https://dx.doi.org/10.1016/j.ijrobp.2022.07.1840 https://www.ncbi.nlm.nih.gov/pubmed/36302496 https://search.proquest.com/docview/2730317270 https://pubmed.ncbi.nlm.nih.gov/PMC9839580 |
Volume | 115 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Za9tAEMcXN4GQl9I77sUUCn0ocq1b6ptrkoamaUJwiN-EVloTmVoKjkwh36yfrK-d2UOSc9DjwcLIK8l4fpqdHc_8xdjbYZAJP09Tywlt38L4Nrd4xD0rFG5oi9iOwhk1Jx9-C_ZPvS9Tf9rr_epULa1qPsiubu0r-R-r4j60K3XJ_oNlm5PiDnyP9sUtWhi3f2XjrqLIV5qUqIFPVp4frWq8oFACzGPT_Xi8rKiujjRa9_RzdopSHVlcYeR5LL6j43i_-0PKdOMtUC1SEvEvZBvchOJLHHVGqdsT0jSQ7EyULoFqcVfxPIbDumllrHvF5d8CR2WmFJ_ahNe8LaRv85IdNYtlc5lKH0xM8LbHRmVmmoXB6HwhdKZ7VqRtDhe_c60c7CcpR_W59bzLhU5C6dRTmww2T52UNcx6t06QOK6pqab5TTn1KIwtjKuma15fdZFqvJ2OD3eVCs2NuUWlOeaDYr6sOEmdOg7pvtISuTsef-6LhQTODVwSZLym9K1iB_3RPbbpoIdE17w5Ojg5O2iCCBtXim3D2Ydbr7rNtsx57oqqbq6arhf_dqKpyQN2Xy-DYKSYfsh6onzEtg51ocdj9tOgDdUMJKCg0QaDNiDaYNCGFm3QaENRQoM2KLRBog0abTBog0YbCG1o0AaN9kcYgQIbCGxAsMGA_e4SDNYgsX7CTvd2J-N9Sz9lxMowSKitLA6HXDh8KHjoOGksct-zoxx_4CjmAoM5kYW2kztCeCmJO_HA4zM7Ffjygzzw3adso6xKscPAtYNg5sReiI7Ry7OY09MocGSKFk657fbZwFgpuVBiMompspwnysIJWTgZhglZuM8iY8tER8Qq0k0Qyj8d-sbYPsEZg_4GTEtRrS4TXLDgTI7rFhzzTLHQfBvDU5-Fa5Q0A0iNfv2TsjiXqvQxLrX8aPj8znO-YNvt7fmSbdTLlXiFEX3NX2v6fwNW5QBc |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+Local+Control+Outcomes+and+Clinical+Prognostic+Factors+in+Localized+Pelvic+Ewing+Sarcoma+Patients+Treated+With+Radiation+Therapy%3A+A+Report+From+the+Children%27s+Oncology+Group&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=Ahmed%2C+Safia+K&rft.au=Witten%2C+Brent+G&rft.au=Harmsen%2C+William+S&rft.au=Rose%2C+Peter+S&rft.date=2023-02-01&rft.eissn=1879-355X&rft.volume=115&rft.issue=2&rft.spage=337&rft_id=info:doi/10.1016%2Fj.ijrobp.2022.07.1840&rft_id=info%3Apmid%2F36302496&rft.externalDocID=36302496 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0360-3016&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0360-3016&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0360-3016&client=summon |